Archive for June, 2003

Biogen/Idec: still a matter of size

Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help the two relatively isolated companies increase presence in their disease areas. The annual R&D budget for the new pharmaceutical entity, to be called Biogen Idec Inc, will be $500 million, according to company reports.


Click here for reuse options!
Copyright 2003 Biotechblog

The State of Biotechnology

The State of Biotechnology Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry Organization’s annual convention. Topics to be addressed at BIO 2003 range from science and regulatory affairs to bioethics and homeland security.


Click here for reuse options!
Copyright 2003 Biotechblog

Coffee Plants Can Produce Less Caffeine

Coffee Plants Can Produce Less Caffeine Researchers say they have genetically engineered coffee plants that have 70 percent less caffeine than usual in their leaves. The crucial question for brewing coffee � whether beans from those plants will have less caffeine � won’t be known for three to four years when the plants mature


Click here for reuse options!
Copyright 2003 Biotechblog

Pfizer's Outlook Improves

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the drug world. And with its $60 billion Pharmacia merger completed in April, the king just got fatter


Click here for reuse options!
Copyright 2003 Biotechblog

Pfizer’s Outlook Improves

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the drug world. And with its $60 billion Pharmacia merger completed in April, the king just got fatter


Click here for reuse options!
Copyright 2003 Biotechblog

FDA approves first nasal mist flu vaccine

FDA approves first nasal mist flu vaccine Most people who avoid flu shots because they fear needles will not have that excuse this season. The Food and Drug administration has approved a flu vaccine that is delivered by a squirt up the nose instead of a shot in the arm.


Click here for reuse options!
Copyright 2003 Biotechblog

Microsoft loses No. 2 ranking in market value to drug maker

Microsoft loses No. 2 ranking in market value to drug maker Microsoft has lost its status as the world’s second-largest corporation to drug maker Pfizer due to slowing sales growth that caused it to miss out on this year’s stock-market rally.


Click here for reuse options!
Copyright 2003 Biotechblog

Report Says More Farmers Don't Follow Biotech Rules

Report Says More Farmers Don’t Follow Biotech Rules A new study, drawn from government data, shows that more farmers are failing to comply with standards governing the planting of genetically modified corn than the industry has claimed. Nearly one-fifth of farms growing the main type of genetically engineered corn, BT corn, are violating government rules […]


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: